Incyte (INCY) to Report Q1 Earnings: Whats in the Cards?
Incytes (INCY) first-quarter 2024 revenues are likely to have been driven by the U.S. sales and royalties from Novartis on…
81,320€
0,69%
Echtzeit-Aktienkurs Incyte Corp.
Bid:
Ask:
Nachrichten zur Incyte Corp. Aktie
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
HONG KONG, China and WILMINGTON, Del., April 01, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”…
Incyte (INCY) Posts Positive Results on Opzelura From HS Study
Incytes (INCY) Opzelura leads to a significantly greater reduction in abscess and inflammatory nodule (AN) count in HS patients.…